DANZIGER ASAF (Chief Executive Officer) received a stock award from NOVOCURE LTD
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2026ACC: 0001654435-26-000003
DirectorOfficer· Chief Executive Officer
Since Jul 2018
+268.00
Net shares
Net buyer
$3.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
268.00 acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+268.00
Price / share
$11.15
Trade value
$2.99K
% of position
0.1%
6/30/2026
416.47K→416.74K
Total
Net shares
+268.00
Net value
$2.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/30/2026 | A · Award | +268.00 | $11.15 | $2.99K | 0.1% | 416.47K | 416.74K |
| Total | +268.00 | $2.99K | ||||||
Derivative Transactions0
No derivative transactions reported